BioCurex, Inc.(fka BOCX)

[HALF FULL GLASS]

New Study Adds to Debate On Prostate Screenings
Associated Press
Word Count: 300
WASHINGTON -- A study from Europe suggests it doesn't hurt to wait a few years between prostate cancer screenings -- but the research won't end debate over the value of PSA tests.

Millions of U.S. men have their blood tested every year for PSA, or prostate-specific antigen, although routine screenings are controversial.

High PSA levels can mean cancer or just an ...

• THE FULL WSJ.com ARTICLE IS ONLY AVAILABLE TO SUBSCRIBERS.• IF YOU ARE ALREADY A SUBSCRIBER, PLEASE LOG IN AT THE TOP RIGHT OF THE PAGE.